A paper recently published in Endocrine Reviews looks to provide readers with an improved understanding in approaches to using hormone therapy to treat menopausal women. The review, by Valerie Flores, MD, and Lubna Pal, MD, of Yale School of Medicine and JoAnn Manson, MD, of Harvard Medical School, points out that hormone therapy remains the...
Men with hypersexual disorder may have higher levels of oxytocin in their blood than men without the disorder, according to a small study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Hypersexual disorder involves excessive, persistent sexual behaviors related to various mood states, with an impulsivity component and experienced loss of control....
COVID-19 Pandemic Associated with Disruptions to Women’s Reproductive Health
Women’s reproductive health has been disrupted as a result of the psychological burden of the COVID-19 pandemic, and affected women need additional medical and psychological support, according to research presented at the Society for Endocrinology annual conference in Edinburgh last November. The findings indicate that stress and sleep disturbance related to the pandemic have had...
Abbott, ADA Launch Community Initiative to Advance Access to Diabetes Care and Technology
Last November, Abbott and the American Diabetes Association (ADA) announced the launch of their first joint community health partnership. The community initiative, which is the first program under the ADA’s Health Equity Now platform, will launch in Columbus, Ohio, and be conducted in partnership with the National Center for Urban Solutions (NCUS), a Columbus-based organization...
Thyroid hormone levels during pregnancy may predict preschool boys’ emotional and behavioral problems, according to a study published in The Journal of Clinical Endocrinology & Metabolism. Thyroid hormones are crucial for normal development of a baby’s brain and nervous system. During the first trimester — the first three months of pregnancy — a baby depends on its...
Postmenopausal Women May Benefit from Estrogen Compound Research
Postmenopausal women have increased risk of non-alcoholic fatty liver disease due to loss of estrogen from metabolic changes. A high-fat diet further exacerbates the disease, which can progress to cirrhosis and liver failure. Hormone replacement therapy (HRT) is an effective treatment, but it carries increased risk of breast cancer, uterine cancers, and cardiovascular disease. Researchers...
In November, the European Medicine Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the granting of a marketing authorization for Ascendis Pharma’s lonapegsomatropin (TransCon hGH), a long-acting once-weekly, transiently pegylated somatropin that in the body releases somatropin, indicated for growth failure in children and adolescents aged from 3 years...
Rapid uptake of long-acting growth hormones (GH) is set to shake up the growth hormone deficiency (GHD) space in the three major markets (3MM): the US, Germany, and Japan. These therapies are projected to capture more than 90% of market share in this region by 2030 due to their potential to improve patient convenience and...
